Publications by authors named "Keisuke Monji"

Claim this Profile
I
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan.
Toshiki Anami, Takanobu Motoshima, Yuto Matsushita, Takahiro Kojima, Shimpei Yamashita, Keisuke Monji

Int J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.
Masayuki Takahashi, Yuto Matsushita, Takahiro Kojima, Takahiro Osawa, Tomokazu Sazuka, Keisuke Monji

Clin Genitourin Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes with avelumab + axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification.
Junya Furukawa, Taigo Kato, Toshinari Yamasaki, Keisuke Monji, Toshiaki Tanaka

Int J Clin Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
Kazutoshi Fujita, Yuto Matsushita, Shingo Toyoda, Takahiro Kojima, Shimpei Yamashita, Keisuke Monji

World J Urol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and future perspective of immunotherapy for renal cell carcinoma.
Leandro Blas, Keisuke Monji, Jun Mutaguchi, Satoshi Kobayashi, Shunsuke Goto

Int J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
Ryotaro Tomida, Masayuki Takahashi, Yuto Matsushita, Takahiro Kojima, Kazutoshi Yamana, Keisuke Monji

Clin Genitourin Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved urinary continence recovery after robot-assisted radical prostatectomy with lateral pelvic fascia preservation.
Masaki Shiota, Shigehiro Tsukahara, Shohei Ueda, Jun Mutaguchi, Shunsuke Goto, Keisuke Monji

J Robot Surg· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive investigation of clinicopathological and immunological features to determine prognostic impact in metastatic renal cell carcinoma: The JEWEL study.
Kojiro Ohba, Keisuke Monji, Takahiro Osawa, Kazutoshi Yamana, Yosuke Yasuda

Int J Urol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Testosterone Level of Seminal Vesicle Fluid in Patients With Prostate Cancer Other Malignancies.
Eiji Kashiwagi, Masaki Shiota, Junichi Inokuchi, Shigehiro Tsukahara, Kenjiro Imada, Keisuke Monji

Anticancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men.
Leandro Blas, Masaki Shiota, Shigehiro Tsukahara, Shunsuke Goto, Fumio Kinoshita, Keisuke Monji

Int J Urol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot-assisted radical prostatectomy.
Ken Lee, Masaki Shiota, Dai Takamatsu, Miho Ushijima, Leandro Blas, Keisuke Monji

Int J Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.
Leandro Blas, Masaki Shiota, Dai Takamatsu, Fumio Kinoshita, Takashi Matsumoto, Keisuke Monji

World J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of user-friendly models predicting extracapsular extension in prostate cancer patients.
Leandro Blas, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Keisuke Monji

Asian J Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancer.
Eiji Kashiwagi, Masaki Shiota, Hidekazu Naganuma, Keisuke Monji, Kenjiro Imada

Int J Urol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoas Muscle Volume Is a Predictive Marker of Fatigue and Anorexia in Prostate Cancer Patients Treated with Enzalutamide.
Eiji Kashiwagi, Masaki Shiota, Ken Lee, Keisuke Monji, Hidekazu Naganuma

JMA J· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of nerve sparing in robot-assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence.
Hiroki Komori, Leandro Blas, Masaki Shiota, Dai Takamatsu, Takashi Matsumoto, Keisuke Monji

Int J Urol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of models predicting lymph node involvement probability in patients with prostate cancer.
Leandro Blas, Masaki Shiota, Shohei Nagakawa, Shigehiro Tsukahara, Takashi Matsumoto, Keisuke Monji

Int J Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.
Hiroki Kobayashi, Masaki Shiota, Nobuaki Sato, Satoshi Kobayashi, Takashi Matsumoto, Keisuke Monji

Anticancer Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors.
Takashi Matsumoto, Masaki Shiota, Shigetomo Yamada, Leandro Blas, Hidekazu Naganuma, Keisuke Monji

JMA J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis.
Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, Hideya Onishi, Tatsuya Hirano, Keisuke Monji

Anticancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of prior local therapy in castration-resistant prostate cancer.
Mikifumi Koura, Masaki Shiota, Shohei Ueda, Takashi Matsumoto, Satoshi Kobayashi, Keisuke Monji

Jpn J Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitors.
Asako Machidori, Masaki Shiota, Satoshi Kobayashi, Takashi Matsumoto, Keisuke Monji

Urol Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Takuya Yamashita, Masaki Shiota, Asako Machidori, Satoshi Kobayashi, Takashi Matsumoto, Keisuke Monji

Cancer Invest· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of antiandrogen withdrawal syndrome in castration-resistant prostate cancer patients treated with abiraterone or enzalutamide.
Masaki Shiota, Asako Machidori, Tatsuro Abe, Keisuke Monji, Eiji Kashiwagi

Int J Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between body composition and hormone sensitivity for androgen deprivation therapy in patients with metastatic prostate cancer.
Eiji Kashiwagi, Masaki Shiota, Hiroyuki Masaoka, Kenjiro Imada, Keisuke Monji

Prostate Int· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis